AAVIN
AAVIN is a private equity firm based in Cedar Rapids, Iowa, founded in 1999. The firm specializes in equity and debt investments across various sectors, including medical services and devices, telecommunications, manufacturing, distribution, industrial products, and software. AAVIN primarily focuses on late-stage and expansion-stage financing, targeting smaller investment opportunities typically under $10 million, with many requests around $5 million. The firm partners with strong management teams to drive internal growth and pursue acquisitions, leveraging its extensive experience in private equity and venture capital. AAVIN's five-member investment team boasts over 120 years of cumulative experience, having invested in more than 125 companies. The firm emphasizes active involvement throughout the investment lifecycle, providing support in areas such as strategic planning, finance, marketing, recruitment, and market analysis.
Celleration
Series D in 2008
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.
Coolibar
Venture Round in 2005
Coolibar is a company based in Minneapolis, Minnesota, that specializes in designing, manufacturing, and marketing sun protection products for individuals of all ages. Founded in 2001, its product range includes sun-protective clothing, swimwear, hats, sunglasses, umbrellas, and various sunscreens and sunblocks. The company focuses on providing effective solutions to protect against harmful UV rays, ensuring that customers can enjoy outdoor activities safely.
WindLogics
Series B in 2004
WindLogics, previously known as SSESCO, specializes in advanced wind analysis and forecasting services tailored for stakeholders in the wind energy sector, including developers, investors, and utilities. The company evaluates potential wind energy sites and offers real-time forecasting and operational optimization. By leveraging exclusive historical weather data and established meteorological models, WindLogics is capable of calculating three-dimensional wind fields, which enhances the accuracy of its analyses. In addition to wind energy, the company also provides solutions for renewable energy project planning and design, including solar plants, contributing to the development of low-cost sustainable power systems.
FENA Design
Venture Round in 2003
FENA Design is a technology-focused design company based in Plymouth, Minnesota, founded in 1992. The company specializes in the design and manufacture of innovative standing power mobility devices, notably its flagship product, the Vertran. This power wheelchair is specifically engineered to enhance mobility for individuals with paraplegia and quadriplegia, allowing users to stand and navigate their environments, including homes, offices, and outdoor spaces. The Vertran aims to provide a range of medical, therapeutic, functional, and personal benefits compared to traditional sitting wheelchair designs, thereby improving overall user experience and independence.
Celleration
Series B in 2002
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.
WindLogics
Series A in 2002
WindLogics, previously known as SSESCO, specializes in advanced wind analysis and forecasting services tailored for stakeholders in the wind energy sector, including developers, investors, and utilities. The company evaluates potential wind energy sites and offers real-time forecasting and operational optimization. By leveraging exclusive historical weather data and established meteorological models, WindLogics is capable of calculating three-dimensional wind fields, which enhances the accuracy of its analyses. In addition to wind energy, the company also provides solutions for renewable energy project planning and design, including solar plants, contributing to the development of low-cost sustainable power systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.